Abvc Biopharma (ABVC) Other Gross PP&E Adjustments (2018 - 2025)
Abvc Biopharma (ABVC) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with $8.7 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 654.74% year-over-year to $8.7 million, compared with a TTM value of $8.7 million through Dec 2025, up 654.74%, and an annual FY2025 reading of $8.7 million, up 654.74% over the prior year.
- Other Gross PP&E Adjustments was $8.7 million for Q4 2025 at Abvc Biopharma, up from $3.3 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $10.8 million in Q3 2024 and bottomed at $1.2 million in Q4 2024.
- Average Other Gross PP&E Adjustments over 5 years is $4.7 million, with a median of $2.7 million recorded in 2022.
- Peak annual rise in Other Gross PP&E Adjustments hit 654.74% in 2025, while the deepest fall reached 69.8% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at $2.0 million in 2021, then rose by 19.7% to $2.4 million in 2022, then rose by 7.2% to $2.5 million in 2023, then tumbled by 54.24% to $1.2 million in 2024, then soared by 654.74% to $8.7 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for ABVC at $8.7 million in Q4 2025, $3.3 million in Q3 2025, and $3.4 million in Q2 2025.